Advances in genomics and proteomics have unveiled an ever-growing number of key proteins and provided mechanistic insights into the genesis of pathologies. This wealth of data showed that changes in expression levels of specific proteins, mutations, and post-translational modifications can result in (often subtle) perturbations of functional protein-protein interaction networks, which ultimately determine disease phenotypes. Although many such validated pathogenic proteins have emerged as ideal drug targets, there are also several that escape traditional pharmacological regulation; these proteins have thus been labeled as undruggable. Challenges posed by undruggable targets call for new sorts of molecular intervention. One fascinating solution is to perturb a pathogenic protein's expression levels, rather than blocking its activities. In this Concept Paper, we will discuss chemical interventions aimed at recruiting undruggable proteins to the Ubiquitin Proteasome System, or aimed at disrupting protein-protein interactions in the chaperone-mediated cellular folding machinery: both kinds of intervention lead to a decrease in the amount of active pathogenic protein expressed. Specifically, we will discuss the role of computational strategies in understanding the molecular determinants characterizing the function of synthetic molecules typically designed for either types of intervention. Finally, we will provide our perspectives and views on current limitations and possibilities to expand the scope of rational approaches to the design of chemical regulators of protein levels.
Exploiting the folding and degradation machineries to target undruggable proteins: What can the computational approach tell us?
Serapian, Stefano A;Castelli, Matteo;Marchetti, Filippo;Triveri, Alice;Colombo, Giorgio
2021-01-01
Abstract
Advances in genomics and proteomics have unveiled an ever-growing number of key proteins and provided mechanistic insights into the genesis of pathologies. This wealth of data showed that changes in expression levels of specific proteins, mutations, and post-translational modifications can result in (often subtle) perturbations of functional protein-protein interaction networks, which ultimately determine disease phenotypes. Although many such validated pathogenic proteins have emerged as ideal drug targets, there are also several that escape traditional pharmacological regulation; these proteins have thus been labeled as undruggable. Challenges posed by undruggable targets call for new sorts of molecular intervention. One fascinating solution is to perturb a pathogenic protein's expression levels, rather than blocking its activities. In this Concept Paper, we will discuss chemical interventions aimed at recruiting undruggable proteins to the Ubiquitin Proteasome System, or aimed at disrupting protein-protein interactions in the chaperone-mediated cellular folding machinery: both kinds of intervention lead to a decrease in the amount of active pathogenic protein expressed. Specifically, we will discuss the role of computational strategies in understanding the molecular determinants characterizing the function of synthetic molecules typically designed for either types of intervention. Finally, we will provide our perspectives and views on current limitations and possibilities to expand the scope of rational approaches to the design of chemical regulators of protein levels.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.